Neural stem cell delivery of oncolytic CRAd-S-pk7 immunotherapy for stage 3 ovarian cancer: Dose-regimen studies.
Mooney R, Ngai G, Kaur G, Kang EY, Lara J, Abd El-Fattah EE, Huang P, Flores L, McDonald M, Talley M, Hammad M, Laidlaw M, Alamillo A, Nguyen DH, Lesniak MS, Curiel DT, Kortylewski M, Santidrian AF, Dellinger T, Aboody KS.
Mooney R, et al. Among authors: laidlaw m.
Mol Ther Oncol. 2026 Apr 27;34(2):201219. doi: 10.1016/j.omton.2026.201219. eCollection 2026 Jun 18.
Mol Ther Oncol. 2026.
PMID: 42179969
Free PMC article.